Propanc Biopharma Secures up to $100 million for Crypto Treasury
Australian company Propanc Biopharma announced it has secured up to $100 million from a crypto-focused family office to launch a crypto treasury – a move its CEO called “transformative” as its cancer therapy product enters human trials next year. The private placement, structured through convertible preferred stock, provides Propanc with an initial investment of $1 … Read more